Antitumor agent-78
Antitumor agent-78 is an antitumor agent, inhibits cancer cells growth and migration. Antitumor agent-78 triggers ferroptosis by inhibiting GPx-4 and elevating COX2. Antitumor agent-78 also activates intrinsic apoptotic pathway (Bax-Bcl-2-caspase-3) and hinders Epithelial-mesenchymal transition (EMT) process of cancer cells.
For research use only. We do not sell to patients.
- CAS No.: 2870703-23-2
- Formula: C13H19F3N2O5Pt
- Molecular Weight:535.38
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
COX-2 |
Bax |
Bcl-2 |
Antitumor agent-78 (compound 2b) (30 μM; 4 h) exhibits good liposoluble and improved cellular uptake in A549 cancer cells[1].
Antitumor agent-78 (20 μM; 36 h) produces cytotoxicity by inducing apoptosis of A549 cancer cells[1].
Antitumor agent-78 (20 μM; 24 h) results in significant down-regulation of Bcl-2 and upregulation of Bax, also leads to E-cadherin increase, Vimentin decrease[1].
Antitumor agent-78 (20 μM; 24 h) arrests cell cycle at S phase and G2/M phase[1].
Antitumor agent-78 (10 μM; 12 h) inhibits cells migration with inhibition rate of 53%[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A549 cells
-
Concentration:20 μM
-
Incubation Time:36 hours
-
Result:Resulte cell apopsotsis with average apoptotic values (including both early and late apoptotic states which were displayed in Q1-LR and Q1-UR, respectively) of 35.86%.
-
Cell Line:A549 cells
-
Concentration:20 μM
-
Incubation Time:24 hours
-
Result:Elevated the level of cleaved caspase-3 and reduced the level of caspase-3 in A549 cells.
Decreased anti-apoptotic protein Bcl-2 and increased pro-apoptotic protein Bax.
Elevated the expression of E-cadherin and on the other hand, lowered the protein level of Vimentin.
-
Cell Line:A549 cells
-
Concentration:20 μM
-
Incubation Time:24 hours
-
Result:Blocked cell cycle progression in S and G2/M phase with the values of 24.91% and 22.21%, respectively.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:A549 xenograft models in mouse[1]
-
Dosage:6 μg/kg
-
Administration:Intravenous injection; administration on day 8, 10, 12 after establishing xenograft models (A549 cells; s.c.)
-
Result:Significantly repressed tumor growth, and maintained normal kidney and liver architecture in mice.
Chemical Information
-
CAS No. 2870703-23-2
-
Molecular Weight 535.38
-
Formula C13H19F3N2O5Pt
-
SMILES
O=C1O[Pt]2(OC(C13CC(C(F)(F)F)(C3)O)=O)[NH2][C@@H]4CCCC[C@H]4[NH2]2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (276 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz